chr5-162067846-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198904.4(GABRG2):​c.-154C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0626 in 664,620 control chromosomes in the GnomAD database, including 1,526 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.058 ( 321 hom., cov: 31)
Exomes 𝑓: 0.064 ( 1205 hom. )

Consequence

GABRG2
NM_198904.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.393
Variant links:
Genes affected
GABRG2 (HGNC:4087): (gamma-aminobutyric acid type A receptor subunit gamma2) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammlian brain, where it acts at GABA-A receptors, which are ligand-gated chloride channels. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene have been associated with epilepsy and febrile seizures. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 5-162067846-C-T is Benign according to our data. Variant chr5-162067846-C-T is described in ClinVar as [Benign]. Clinvar id is 352633.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-162067846-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.068 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GABRG2NM_198904.4 linkuse as main transcriptc.-154C>T 5_prime_UTR_variant 1/10 ENST00000639213.2 NP_944494.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GABRG2ENST00000639213.2 linkuse as main transcriptc.-154C>T 5_prime_UTR_variant 1/101 NM_198904.4 ENSP00000491909 A1P18507-2

Frequencies

GnomAD3 genomes
AF:
0.0581
AC:
8821
AN:
151946
Hom.:
321
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0314
Gnomad AMI
AF:
0.0537
Gnomad AMR
AF:
0.0493
Gnomad ASJ
AF:
0.0726
Gnomad EAS
AF:
0.0414
Gnomad SAS
AF:
0.0257
Gnomad FIN
AF:
0.117
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0697
Gnomad OTH
AF:
0.0651
GnomAD4 exome
AF:
0.0639
AC:
32762
AN:
512556
Hom.:
1205
Cov.:
5
AF XY:
0.0619
AC XY:
17140
AN XY:
276846
show subpopulations
Gnomad4 AFR exome
AF:
0.0338
Gnomad4 AMR exome
AF:
0.0430
Gnomad4 ASJ exome
AF:
0.0710
Gnomad4 EAS exome
AF:
0.0403
Gnomad4 SAS exome
AF:
0.0259
Gnomad4 FIN exome
AF:
0.108
Gnomad4 NFE exome
AF:
0.0710
Gnomad4 OTH exome
AF:
0.0663
GnomAD4 genome
AF:
0.0580
AC:
8816
AN:
152064
Hom.:
321
Cov.:
31
AF XY:
0.0581
AC XY:
4318
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.0313
Gnomad4 AMR
AF:
0.0491
Gnomad4 ASJ
AF:
0.0726
Gnomad4 EAS
AF:
0.0415
Gnomad4 SAS
AF:
0.0255
Gnomad4 FIN
AF:
0.117
Gnomad4 NFE
AF:
0.0697
Gnomad4 OTH
AF:
0.0653
Alfa
AF:
0.0683
Hom.:
409
Bravo
AF:
0.0525
Asia WGS
AF:
0.0390
AC:
136
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 14, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Epilepsy, childhood absence 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
8.5
DANN
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3219203; hg19: chr5-161494852; API